Deutsche Bank AG reissued their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Wednesday morning. They currently have a GBX 1,870 ($23.14) price objective on the stock.
A number of other research firms have also recently weighed in on GSK. Shore Capital restated a hold rating on shares of GlaxoSmithKline plc in a report on Wednesday, July 27th. Jefferies Group upgraded GlaxoSmithKline plc to a buy rating and upped their price target for the stock from GBX 1,650 ($20.42) to GBX 2,000 ($24.75) in a report on Thursday, July 14th. BNP Paribas restated a neutral rating and issued a GBX 1,430 ($17.70) price target on shares of GlaxoSmithKline plc in a report on Sunday, July 3rd. Independent Research GmbH set a GBX 1,800 ($22.28) price target on GlaxoSmithKline plc and gave the stock a neutral rating in a report on Thursday, August 4th. Finally, JPMorgan Chase & Co. restated a neutral rating on shares of GlaxoSmithKline plc in a report on Thursday, September 22nd. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and eight have issued a buy rating to the company. GlaxoSmithKline plc currently has an average rating of Hold and a consensus target price of GBX 1,687.13 ($20.88).
GlaxoSmithKline plc (LON:GSK) opened at 1674.50 on Wednesday. The stock has a 50 day moving average of GBX 1,650.69 and a 200-day moving average of GBX 1,561.99. GlaxoSmithKline plc has a one year low of GBX 1,277.25 and a one year high of GBX 1,745.56. The firm’s market capitalization is GBX 81.40 billion.
The company also recently announced a dividend, which was paid on Thursday, October 13th. Investors of record on Thursday, August 11th were issued a dividend of GBX 19 ($0.24) per share. This represents a yield of 1.12%. The ex-dividend date of this dividend was Thursday, August 11th.
In related news, insider Slaoui,Moncef purchased 28 shares of the firm’s stock in a transaction that occurred on Friday, August 12th. The stock was acquired at an average price of GBX 2,208 ($27.33) per share, for a total transaction of £618.24 ($765.15). Also, insider Witty,Sir Andrew P sold 10,000 shares of the stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($20.95), for a total value of £169,300 ($209,529.70).
About GlaxoSmithKline plc
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.